Published in Vet Pathol on October 03, 2013
Animal Models of Bone Metastasis. Vet Pathol (2015) 0.84
Murine models of breast cancer bone metastasis. Bonekey Rep (2016) 0.80
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer. J Vis Exp (2016) 0.75
Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin. PLoS One (2017) 0.75
Inflammation and cancer. Nature (2002) 53.78
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 17.49
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
Microenvironmental regulation of metastasis. Nat Rev Cancer (2008) 15.76
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol (1992) 12.96
Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer (2002) 12.45
Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol (1989) 7.47
Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature (1983) 7.20
Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature (1985) 7.10
Integrin signalling during tumour progression. Nat Rev Mol Cell Biol (2004) 6.53
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest (2005) 6.10
The pathogenesis of cancer metastasis. Nature (1980) 5.74
Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol (1993) 5.22
Cancer to bone: a fatal attraction. Nat Rev Cancer (2011) 4.08
Tumor measurement in the nude mouse. J Surg Oncol (1986) 4.01
The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia (2004) 3.54
Critical determinants of metastasis. Semin Cancer Biol (2002) 3.12
Immune cells as mediators of solid tumor metastasis. Cancer Metastasis Rev (2008) 2.85
Matrix metalloproteinases and the development of cancer. Chem Biol (1996) 2.63
Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis (2005) 2.52
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res (2001) 2.44
Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Nat Rev Cancer (2002) 2.15
MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet (2007) 2.14
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98
Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res (2004) 1.76
Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol (2010) 1.68
The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol (2003) 1.63
Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacol Ther (2008) 1.52
Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis. Cancer Res (2010) 1.51
Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS (1999) 1.49
Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis. Cancer Metastasis Rev (1991) 1.46
Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer (2005) 1.46
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. Am J Pathol (2005) 1.32
Cell transformation by the middle T-antigen of polyoma virus. Oncogene (2001) 1.31
Animal models of bone metastasis. Cancer (2003) 1.29
Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res (2004) 1.27
Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer (2009) 1.27
Validity of mouse mammary tumour models for human breast cancer: comparative pathology. Microsc Res Tech (2001) 1.20
Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp (1998) 1.18
Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. Prostate (2010) 1.15
New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft. Prostate (2006) 1.15
Pre-clinical mouse models of human prostate cancer and their utility in drug discovery. Curr Protoc Pharmacol (2010) 1.12
Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases. Biochim Biophys Acta (2007) 1.07
Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. FASEB J (2007) 1.02
Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma. Am J Surg (2006) 1.00
Potential for targeting the fibroblast growth factor receptors in breast cancer. Cancer Res (2010) 0.99
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Breast Cancer Res Treat (2007) 0.98
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis (2004) 0.98
Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases. Clin Exp Metastasis (2007) 0.95
An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. PLoS One (2012) 0.95
The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice. Clin Exp Metastasis (2006) 0.95
A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone. J Clin Oncol (2006) 0.93
Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. Br J Cancer (2007) 0.92
Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Res (2010) 0.91
Effect of organ-specific fibroblasts on proliferation and differentiation of breast cancer cells. Breast Cancer Res Treat (2005) 0.88
Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice. Clin Exp Metastasis (2011) 0.88
Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein. Prostate (1999) 0.87
Alternative splicing of parathyroid hormone-related protein mRNA: expression and stability. J Mol Endocrinol (2004) 0.85
Development of a brain metastatic canine prostate cancer cell line. Prostate (2011) 0.85
Loss of E-cadherin in the vicinity of necrosis in colorectal carcinomas: association with NFkappaB expression. Int J Oncol (2007) 0.85
Tumor resection and antibodies to parathyroid hormone-related protein cause similar changes on bone histomorphometry in hypercalcemia of cancer. Endocrinology (1990) 0.85
Cytokine control of cell motility: modulation and mediation by the extracellular matrix. Prog Growth Factor Res (1994) 0.82
Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth. PLoS One (2012) 0.81
At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone. Odontology (2012) 0.78
Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia. Leukemia (2014) 0.93
Animal Models of Bone Metastasis. Vet Pathol (2015) 0.84